Challenging issues in randomised controlled trials.

Area of Science:

• Clinical Research Methodology
• Evidence-Based Medicine
• Biostatistics

Background:

• Randomized controlled trials (RCTs) are the gold standard for establishing causality between treatments and outcomes.
• Understanding RCT design is essential for interpreting medical literature and guiding clinical practice.
• High-quality RCTs are fundamental to the hierarchy of evidence in healthcare.

Purpose of the Study:

• To elucidate key components of robust randomized controlled trial (RCT) design.
• To identify common challenges and pitfalls that compromise RCT quality.
• To provide practical guidance for researchers to enhance the rigor of their RCTs.

Main Methods:

• The article reviews essential elements of RCT design.
• It uses examples from ongoing trauma studies coordinated by the Australian and New Zealand Intensive Care Research Centre.
• Common methodological flaws are discussed in detail.

Main Results:

• Key pitfalls include unclear hypotheses, poor endpoint selection, inappropriate subject criteria, and non-feasible interventions.
• Inadequate randomization, stratification, blinding, and insufficient sample size are frequently observed issues.
• Failure to use intention-to-treat analysis and anticipate practical challenges also impacts RCT quality.

Conclusions:

• Addressing common pitfalls in RCT design is vital for improving study quality and impact.
• RCTs that proactively manage design challenges are more likely to secure funding and yield high-quality results.
• Attention to detail in RCT methodology ensures the reliability of findings for clinical decision-making.